Company intelligence / Profile preview
CureDM, Inc.
Wynnewood, Pennsylvania, United Statescuredm.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
CureDM developed a novel human peptide ("HIP" or "HIP2B") that stimulates differentiation of new insulin-producing pancreatic islets from adult progenitor cells. The approach aims to restore endogenous insulin production and potentially allow discontinuation of exogenous insulin therapy for diabetes patients. As of the latest available information, their lead compound was advancing through preclinical studies with plans for IND submission but no published clinical results yet[1][3].
- Therapeutic areas
- Endocrinology
- Modalities
- Peptides (notably Human proIslet Peptide/HIP2B)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Sanofi-Aventis partnered with CureDM to develop its novel diabetes treatment candidate PancreateTM[4]University of Pennsylvania Human Islet LaboratoryCalvert Research Institute/Calvert HoldingsScientific Health Development Ltd.[3]
Beyond the preview
Go deeper on CureDM, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CureDM, Inc..